-
Story /University students majoring in the life sciences or business often have trouble imagining the direction of their careers.
-
Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
-
Story /Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
-
Featured News /
The Co-Creating Impact Summit happening on December 9th, 2020, will gather experts inside and outside of Novartis to continue our work of improving our impact on the society and the planet.
-
Featured News /Annual meeting highlights progress on the company’s transformation and growth strategy.
-
Story /Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.
-
Story /Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.
-
Story /Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.
-
Story /Hundreds of millions of people worldwide await treatments for rare diseases.
-
Story /Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.
Pagination
- ‹ Previous page
- 1
- …
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- …
- 278
- › Next page